Envista Holdings Corp (NVST)
Healthcare
Medical Instruments & Supplies
27.30 $
Closing price · As of: 31. Jul 2026
Who owns Envista Holdings Corp (NVST)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.6% of the shares are freely tradable; institutional investors hold 113.4%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
113.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
99.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
8.3%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
163Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 10.97 | 17,852,827 | +1.8 | 03/31/2026 |
| Vanguard Group Inc | 9.89 | 16,096,482 | -1.8 | 12/31/2025 |
| Ariel Investments, LLC | 6.68 | 10,863,592 | -9.2 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 6.01 | 9,780,948 | +1.6 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 5.40 | 8,793,137 | -0.2 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.65 | 7,566,721 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.50 | 7,318,581 | +0.0 | 03/31/2026 |
| Franklin Resources Inc | 4.24 | 6,894,025 | -14.5 | 03/31/2026 |
| Gates Capital Management Inc | 3.30 | 5,362,711 | -7.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3.42 | 5,560,065 | +0.0 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.